Import Niraparib In India PowerPoint PPT Presentations

Niraparib is a prescription medication used to treat adults who have advanced ovarian cancer, fallopian tube cancer, or primary peritoneal cancer. Continue reading to learn more about this drug. Visit Us: https://synergydrugs.com/products/niraparib-in-india

The PARP inhibitors market is expected to be a consolidated market, with major players such as AstraZeneca, GlaxoSmithKline, and Merck Co. & Inc. generating a large chunk of revenue. Through various collaborative efforts with regional players, these big players are expected to enhance their regional presence in the global PARP inhibitors market.

Some of the market players featured in the report are Koninklijke Philips N.V., EMCO Meditek Pvt. Ltd., Nonin, and IRadimed Corporation

The global PARP inhibitors market is estimated to be valued at US$ 8.4 Bn by 2026, expanding at a significant CAGR from 2019 to 2026.